AstraZeneca (LON:AZN) PT Lowered to £125

AstraZeneca (LON:AZN – Free Report) had its price objective decreased by Jefferies Financial Group from £130 ($164.20) to £125 ($157.89) in a research note released on Monday morning, MarketBeat Ratings reports. Jefferies Financial Group currently has a buy rating on the biopharmaceutical company’s stock. Several other research firms have also recently commented on AZN. JPMorgan […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Downgrades Eltek (NASDAQ:ELTK) to Buy
Next post Royal Bank of Canada Upgrades Mondelez International (NASDAQ:MDLZ) to “Outperform”